Determinan Economic Value Added (EVA) pada Perusahaan Sektor Kesehatan yang Terdaftar di Bursa Efek Indonesia

Authors

  • Raihan Maulana Jailani Universitas Islam Nusantara Author
  • Nani Ernawati Universitas Islam Nusantara Author
  • Yulianita Rahayu Universitas Islam Nusantara Author
  • Mochammad Rizaldy Insan baihaqqy Universitas Islam Nusantara Author

DOI:

https://doi.org/10.65310/jgkx6d93

Keywords:

Economic Value Added, Current Ratio, Debt to Equity Ratio, Operational Efficiency, Return on Assets

Abstract

This study examines the determinants of Economic Value Added (EVA) in healthcare sector companies listed on the Indonesia Stock Exchange during 2019–2025. Using a quantitative causal approach, the study analyzes 84 firm-year observations from 12 companies selected through purposive sampling. The independent variables consist of Current Ratio, Debt to Equity Ratio, Return on Assets, Total Asset Turnover, and Operational Efficiency, while EVA serves as the dependent variable. Panel data regression with the Fixed Effect Model and White cross-section covariance was employed to obtain robust estimates. The results indicate that Current Ratio, Debt to Equity Ratio, Total Asset Turnover, and Operational Efficiency do not significantly affect EVA individually. In contrast, Return on Assets has a positive and significant effect on EVA. Simultaneously, all independent variables significantly influence EVA, with an Adjusted R-squared of 0.914873, indicating that 91.49% of EVA variation is explained by the model. These findings emphasize the importance of asset profitability in creating economic value and support integrated financial management strategies for healthcare companies. Effective asset utilization therefore remains central to strengthening shareholder value creation and long-term corporate performance.

 

Downloads

Download data is not yet available.

References

Agata, & Ruzikna. (2023). Pengaruh Return on Assets (ROA) dan Economic Value Added (EVA) terhadap Kinerja Keuangan pada PT Kimia Farma Tbk.

Anisah, Murad, M. A., Asriadi, Samudra, S., & Magfirah, D. (2023). Indonesian pharmaceutical companies: Capital structure, business risk, company value and firm size as a moderating variable analysis. International Journal of Social Service and Research, 3(1), 122–128. https://doi.org/10.46799/ijssr.v3i1.223

Asnawi, S. K., Wiranata, T., Samsuki, C., Syane, & Julanda, S. (2022). The evaluation of firm performance among EVA and accounting profit: Harmony? Journal of Management and Leadership, 5(2), 14–27. https://doi.org/10.47970/jml.v5i2.337

Banerjee, P., & Deb, S. G. (2023a). Capital investment, working capital management, and firm performance: Role of managerial ability in US logistics industry. Transportation Research Part E: Logistics and Transportation Review, 176, 103224. https://doi.org/10.1016/j.tre.2023.103224

Banerjee, P., & Deb, S. G. (2023b). Working capital management efficiency, managerial ability, and firm performance: New insights. Applied Economics, 56(33), 4001–4018. https://doi.org/10.1080/00036846.2023.2208857

Basuki, A. T., & Prawoto, N. (2017). Analisis Regresi dalam Penelitian Ekonomi dan Bisnis: Dilengkapi Aplikasi SPSS dan EViews. Depok: PT Raja Grafindo Persada.

Ben Hmiden, O., Rjiba, H., & Saadi, S. (2022). Competition through environmental CSR engagement and cost of equity capital. Finance Research Letters, 47, 102773. https://doi.org/10.1016/j.frl.2022.102773

Boulhaga, M., Bouri, A., Elamer, A. A., & Ibrahim, B. A. (2023). Environmental, social and governance ratings and firm performance: The moderating role of internal control quality. Corporate Social Responsibility and Environmental Management, 30(1), 134–145. https://doi.org/10.1002/csr.2343

Brigham, E. F., & Ehrhardt, M. C. (2020). Financial Management: Theory & Practice. Boston: Cengage Learning.

Brigham, E. F., & Houston, J. F. (2019). Fundamentals of Financial Management. Boston: Cengage Learning.

Çam, İ., & Özer, G. (2022). Intellectual capital and firm value: An investigation of Turkish manufacturing companies. Istanbul Business Research, 51(1), 257–277. https://doi.org/10.26650/ibr.2022.51.879113

Chen, Y., Jin, Z., & Qin, B. (2023). Economic Value Added in performance measurement: A simulation approach and empirical evidence. Accounting & Finance, 63(1), 109–140. https://doi.org/10.1111/acfi.13053

Chen, Y., Li, T., Zeng, Q., & Zhu, B. (2023). Effect of ESG performance on the cost of equity capital: Evidence from China. International Review of Economics & Finance, 83, 348–364. https://doi.org/10.1016/j.iref.2022.09.001

Dhany, U. R., Koeshardjono, H., & Agustin, I. (2023). Pengukuran kinerja keuangan menggunakan alat ukur Economic Value Added (EVA) dan Market Value Added (MVA). Jurnal Ilmiah Ecobuss, 11(1), 35–41. https://doi.org/10.51747/ecobuss.v11i1.1339

Dua, J., & Sharma, A. K. (2024). Corporate sustainability and capital costs: A panel evidence from BRICS countries. Indian Journal of Corporate Governance, 17(1), 77–101. https://doi.org/10.1177/09746862241240368

Fandella, P., Sergi, B. S., & Sironi, E. (2023). Corporate social responsibility performance and the cost of capital in BRICS countries: The problem of selectivity using environmental, social and governance scores. Corporate Social Responsibility and Environmental Management, 30(4), 1712–1722. https://doi.org/10.1002/csr.2447

Gonçalves, T. C., Dias, J., & Barros, V. (2022). Sustainability performance and the cost of capital. International Journal of Financial Studies, 10(3), 63. https://doi.org/10.3390/ijfs10030063

Habib, A. M., & Dalwai, T. (2024). Does the efficiency of a firm's intellectual capital and working capital management affect its performance? Journal of the Knowledge Economy, 15, 3202–3238. https://doi.org/10.1007/s13132-023-01138-7

Jung, Y. L., & Yoo, H. S. (2023). Environmental, social, and governance activities and firm performance: Global evidence and the moderating effect of market competition. Corporate Social Responsibility and Environmental Management, 30(6), 2830–2839. https://doi.org/10.1002/csr.2518

Kasmir. (2019). Analisis Laporan Keuangan. Jakarta: Raja Grafindo Persada.

Khanchel, I., & Lassoued, N. (2022). ESG disclosure and the cost of capital: Is there a ratcheting effect over time? Sustainability, 14(15), 9237. https://doi.org/10.3390/su14159237

Kiymaz, H., Haque, S., & Choudhury, A. A. (2024). Working capital management and firm performance: A comparative analysis of developed and emerging economies. Borsa Istanbul Review, 24(3), 634–642. https://doi.org/10.1016/j.bir.2024.03.004

Lim, W. C., & Naysary, B. (2022). Capital structure and corporate performance of listed healthcare companies in Malaysia. PEOPLE: International Journal of Social Sciences, 8(1), 17–35. https://doi.org/10.20319/pijss.2022.81.1735

Lombogia, J. R., Malau, Y. N., Rosadi, F., & Monica, A. G. (2021). Analisis Pengaruh Economic Value Added (EVA), Total Asset Turnover (TATO), dan Current Ratio (CR) terhadap Kinerja Keuangan Perusahaan.

Miao, M., Khan, M. I., Ghauri, S. P., & Zaman, S. I. (2023). The effect of corporate governance on firm performance: Perspectives from an emerging market. Economic Research-Ekonomska Istraživanja, 36(3), 2277275. https://doi.org/10.1080/1331677X.2023.2277275

Munawaroh, M. M., Supeni, R. E., & Hafidzi, A. H. (2024). Analisis Economic Value Added (EVA) untuk mengukur kinerja keuangan pada perusahaan sektor kesehatan dan sektor industrial. Improvement: Jurnal Manajemen dan Bisnis, 4(2), 122–128. https://doi.org/10.30651/imp.v4i2.23479

Olson, G. T., & Pagano, M. S. (2024). Applying the empirical average cost of capital: Estimating the cost of funds at the firm and industry levels. Applied Economics, 56(49), 5921–5938. https://doi.org/10.1080/00036846.2023.2266603

Prasad, K., Kumar, S., Devji, S., Lim, W. M., Prabhu, N., & Moodbidri, S. (2022). Corporate social responsibility and cost of capital: The moderating role of policy intervention. Research in International Business and Finance, 60, 101620. https://doi.org/10.1016/j.ribaf.2022.101620

Rehman, A., Gonenc, H., & Hermes, N. (2023). Carbon disclosure policy, external financing needs and the cost of capital: Does financial market quality matter? Business Strategy and the Environment, 32(8), 5854–5872. https://doi.org/10.1002/bse.3452

Rodríguez, R. A. (2024). A novel approach to calculate weighted average cost of capital (WACC) considering debt and firm's cash flow durations. Managerial and Decision Economics, 45(2), 1154–1179. https://doi.org/10.1002/mde.4042

Senarathne, C. W., & Perera, T. R. (2022). Explaining the impact of financial leverage on firm performance in the healthcare sector in Sri Lanka by fixed cost coverage ratio. Management of Organizations: Systematic Research, 86(1), 77–91. https://doi.org/10.1515/mosr-2021-0014

Stewart, G. B. (2013). Best-Practice EVA: The Definitive Guide to Measuring and Maximizing Shareholder Value. Hoboken: Wiley.

Sugiyono. (2020). Metode Penelitian Kuantitatif, Kualitatif, dan R&D. Bandung: Alfabeta.

Susan, M., & Winarto, J. (2023). Kinerja keuangan dan nilai perusahaan sektor farmasi. Jurnal Informatika Ekonomi Bisnis, 5(4), 1422–1426. https://doi.org/10.37034/infeb.v5i4.729

Tanjung, M. (2023). Cost of capital and firm performance of ESG companies: What can we infer from COVID-19 pandemic? Sustainability Accounting, Management and Policy Journal, 14(6), 1242–1267. https://doi.org/10.1108/SAMPJ-07-2022-0396

Tripathi, P. M., Chotia, V., Solanki, U., Meena, R., & Khandelwal, V. (2023). Economic Value Added research: Mapping thematic structure and research trends. Risks, 11(1), 9. https://doi.org/10.3390/risks11010009

Truong, B. T. T., Nguyen, P. V., & Vrontis, D. (2024). Enhancing firm performance through innovation: The roles of intellectual capital, government support, knowledge sharing and knowledge management success. Journal of Intellectual Capital, 25(1), 188–209. https://doi.org/10.1108/JIC-08-2023-0181

Yang, A. S., & Yulianto, F. A. (2022). Cost of equity and corporate social responsibility for environmental sensitive industries: Evidence from international pharmaceutical and chemical firms. Finance Research Letters, 47, 102532. https://doi.org/10.1016/j.frl.2021.102532

Downloads

Published

2026-09-04

How to Cite

Determinan Economic Value Added (EVA) pada Perusahaan Sektor Kesehatan yang Terdaftar di Bursa Efek Indonesia. (2026). Journal of Economic and Business Advancement, 2(1), 243-254. https://doi.org/10.65310/jgkx6d93